150 related articles for article (PubMed ID: 21709054)
1. A variety of novel lipid A structures obtained from Francisella tularensis live vaccine strain.
Beasley AS; Cotter RJ; Vogel SN; Inzana TJ; Qureshi AA; Qureshi N
Innate Immun; 2012 Apr; 18(2):268-78. PubMed ID: 21709054
[TBL] [Abstract][Full Text] [Related]
2. Novel modification of lipid A of Francisella tularensis.
Phillips NJ; Schilling B; McLendon MK; Apicella MA; Gibson BW
Infect Immun; 2004 Sep; 72(9):5340-8. PubMed ID: 15322031
[TBL] [Abstract][Full Text] [Related]
3. Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.
Richard K; Mann BJ; Stocker L; Barry EM; Qin A; Cole LE; Hurley MT; Ernst RK; Michalek SM; Stein DC; Deshong P; Vogel SN
Clin Vaccine Immunol; 2014 Feb; 21(2):212-26. PubMed ID: 24351755
[TBL] [Abstract][Full Text] [Related]
4. Characterization of lipid A acylation patterns in Francisella tularensis, Francisella novicida, and Francisella philomiragia using multiple-stage mass spectrometry and matrix-assisted laser desorption/ionization on an intermediate vacuum source linear ion trap.
Schilling B; McLendon MK; Phillips NJ; Apicella MA; Gibson BW
Anal Chem; 2007 Feb; 79(3):1034-42. PubMed ID: 17263332
[TBL] [Abstract][Full Text] [Related]
5. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
Li J; Ryder C; Mandal M; Ahmed F; Azadi P; Snyder DS; Pechous RD; Zahrt T; Inzana TJ
Microbiology (Reading); 2007 Sep; 153(Pt 9):3141-3153. PubMed ID: 17768257
[TBL] [Abstract][Full Text] [Related]
6. Evidence Suggesting That Francisella tularensis O-Antigen Capsule Contains a Lipid A-Like Molecule That Is Structurally Distinct from the More Abundant Free Lipid A.
Barker JH; Kaufman JW; Apicella MA; Weiss JP
PLoS One; 2016; 11(6):e0157842. PubMed ID: 27326857
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW
Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Inner and Outer Membrane Proteins from
Post DMB; Slütter B; Schilling B; Chande AT; Rasmussen JA; Jones BD; D'Souza AK; Reinders LM; Harty JT; Gibson BW; Apicella MA
mBio; 2017 Oct; 8(5):. PubMed ID: 29018123
[No Abstract] [Full Text] [Related]
9. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
[TBL] [Abstract][Full Text] [Related]
10. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
Jia Q; Bowen R; Sahakian J; Dillon BJ; Horwitz MA
Infect Immun; 2013 May; 81(5):1550-61. PubMed ID: 23439306
[TBL] [Abstract][Full Text] [Related]
11. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
[No Abstract] [Full Text] [Related]
12. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
Green M; Choules G; Rogers D; Titball RW
Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
[TBL] [Abstract][Full Text] [Related]
13. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
14. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.
Golovliov I; Twine SM; Shen H; Sjostedt A; Conlan W
PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032
[TBL] [Abstract][Full Text] [Related]
15. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
[TBL] [Abstract][Full Text] [Related]
16. Structure and biosynthesis of free lipid A molecules that replace lipopolysaccharide in Francisella tularensis subsp. novicida.
Wang X; Ribeiro AA; Guan Z; McGrath SC; Cotter RJ; Raetz CR
Biochemistry; 2006 Dec; 45(48):14427-40. PubMed ID: 17128982
[TBL] [Abstract][Full Text] [Related]
17. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
18. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.
Kieffer TL; Cowley S; Nano FE; Elkins KL
Microbes Infect; 2003 Apr; 5(5):397-403. PubMed ID: 12737995
[TBL] [Abstract][Full Text] [Related]
19. Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).
Twine SM; Petit MD; Fulton KM; House RV; Conlan JW
PLoS One; 2010 Apr; 5(4):e10000. PubMed ID: 20368994
[TBL] [Abstract][Full Text] [Related]
20. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
